Analysis on the output of pharmaceutical papers and highly cited papers in Double First-rate universities / 药学实践杂志

ABSTRACT

Objective To understand the current situation of pharmaceutical research development in China and provide a constructive thinking for universities to serve the national innovation strategy through the statistical analysis of pharmaceutical papers and highly cited papers from Double First-rate universities. Methods CNKI, Wanfang, VIP and Chinese Biomedical Literature Database were searched for Chinese publications, and Scopus database was searched for English publications. Duplicates and non-research literatures were excluded. Excel 2016 software was used for statistical data analysis. Results By comparing the data from 2017 to 2019 with that from 2014 to 2016, it was found that the number of papers in Q1 area from international journals and Q2 area from domestic journals increased significantly. The popularity of publishing papers in international journals by university authors was increasing. The number of publications in domestic journals slightly decreased. From 2014 to 2020, 850 papers were published in domestic journals, among which 223 papers were highly cited, with a total cited times of 2 410 and an average cited times per publication of 10.81. Conclusion In spite of the government’s encouragement to publish the scientific and technological achievements in domestic journals, no such trend was formed from our analysis. Therefore, it is necessary to further build the corresponding academic ecology and enhance the international influence of domestic journals. The science and technology circles and technology publication circles in China should be deeply integrated to promote mutual development.